A032103: MODERN: An Integrated Phase 2/3 and Phase 3 trial of MRD-Based Optimization of Adjuvant Therapy in Urothelial Cancer
- Title
- MODERN: An Integrated Phase 2/3 and Phase 3 trial of MRD-Based Optimization of Adjuvant Therapy in Urothelial Cancer
- Principal Investigator
- Siddiqui, Raheel
- Phase
- II/III
- Age Group
- Adult
- Applicable Disease Sites
- Genitourinary Cancers
- Participating Institutions
- Mary Babb Randolph Cancer Center
- Contacts
- Jill Stone, LPN
- Research Specialist
- Phone: +1 304-634-4417
- Email: jill.stone@hsc.wvu.edu